LYSOGENE is a company whose main activities include the basic research and clinical development of gene therapy for neurodegenerative disorders. The Company aims to radically improve the health of patients suffering from incurable life threatening conditions. LYSOGENE does this by developing AAV vectors that have demonstrated their effectiveness in safely delivering genetic material to the central nervous system.
Market capitalization (8-Sept-2021)
Closing stock price (8-Sept-2021)
When was LYSOGENE founded?
LYSOGENE was founded in 2009.
Who are LYSOGENE key executives?
LYSOGENE's key executives are Ralph Laufer, Karen Pignet-Aiach and Sophie Olivier.
How many employees does LYSOGENE have?
LYSOGENE has 22 employees.
Who are LYSOGENE competitors?
Competitors of LYSOGENE include Teknova, Genematrix and OmniSeq.
Where is LYSOGENE headquarters?
LYSOGENE headquarters is located at 18 Rue Jacques Dulud, Neuilly-sur-Seine.
Where are LYSOGENE offices?
LYSOGENE has offices in Neuilly-sur-Seine and Cambridge.
How many offices does LYSOGENE have?
LYSOGENE has 2 offices.
Receive alerts for 300+ data fields across thousands of companies